Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
08:09 | Notice to attend the annual general meeting of SyntheticMR AB (publ) | 1 | Cision News | ||
07:39 | SYNTHETICMR AB: SyntheticMR publishes annual report for 2023 | 1 | Cision News | ||
Mi | SYNTHETICMR AB: SyntheticMR and SimonMed Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from SyntheticMR's SyMRI NEURO Software at SimonMed Facilities. | 1 | Cision News | ||
27.03. | SyntheticMR wins FDA clearance for 3D brain scanner | 1 | MassDevice | ||
27.03. | SYNTHETICMR AB: SyntheticMR receives FDA 510(k) clearance for their next Generation Solution SyMRI 3D | 1 | Cision News | ||
12.03. | SYNTHETICMR AB: Decided allocation regarding incentive program LTIP 2024 and TO 2 | 1 | Cision News | ||
05.03. | SYNTHETICMR AB: Fixed subscription price for warrants of series TO 2 and TO 3 | 1 | Cision News | ||
04.03. | Philips (PHG), SyntheticMR Unite to Aid Brain Diagnosing Space | 5 | Zacks | ||
01.03. | Philips, SyntheticMR partner on AI-based brain imaging | 4 | MassDevice | ||
01.03. | SyntheticMR AB: Philips teams with SyntheticMR to deliver breakthrough AI-based quantitative brain imaging in MR to advance neurology care for patients | 533 | PR Newswire | LINKÖPING, Sweden, March 1, 2024 /PRNewswire/ -- Royal Philips (NYSE: PHG) (AEX: PHIA), a global leader in health technology, and magnetic resonance imaging (MRI) software solutions company... ► Artikel lesen | |
27.02. | SYNTHETICMR AB: Subscription price for shares in the incentive program LTIP 2024 | 2 | Cision News | ||
20.02. | Report from the extraordinary general meeting in SyntheticMR AB (publ) | 1 | Cision News | ||
20.02. | SYNTHETICMR AB: Year-End report January - December 2023 | 1 | Cision News | ||
19.01. | Notice to attend the extraordinary general meeting of SyntheticMR AB (publ) | 1 | Cision News | ||
18.01. | SyntheticMR AB intends to introduce incentive programs for the company's staff | 1 | Cision News | ||
18.12.23 | SyntheticMR AB: SyMRI 3D by SyntheticMR Set for Early 2024 Commercial Launch Post Obtaining CE-Marking | 360 | PR Newswire | LINKÖPING, Sweden, Dec. 18, 2023 /PRNewswire/ -- SyntheticMR announced today that their next-generation imaging solution with isotropic 3D resolution, SyMRI 3D, has obtained approval in the... ► Artikel lesen | |
13.12.23 | SYNTHETICMR AB: SYNTHETICMR RECEIVES SIGNIFICANT ORDER FROM OEM PARTNER | 2 | Cision News | ||
30.11.23 | SyntheticMR AB: SyntheticMR and Philips Announce Expanded Global Partnership for SyMRI 3D | 494 | PR Newswire | LINKÖPING, Sweden, Nov. 30, 2023 /PRNewswire/ -- SyntheticMR announced today that they have expanded their partnership with Philips to include SyMRI 3D.
The expanded agreement between... ► Artikel lesen | |
22.11.23 | SYNTHETICMR AB: SyntheticMR Has Submitted Their Next Generation Solution, SyMRI 3D for 510(k) Clearance | 1 | Cision News | ||
17.11.23 | SYNTHETICMR AB: Nomination Committee appointed for the 2024 Annual General Meeting in SyntheticMR | 1 | Cision News |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 26,900 | +0,94 % | wO Börsenlounge: Barrick Gold | Telix | Fresenius - Intel eifert Nvidia nach! | Für Intel steht in China ein großer Teil des Umsatzes im Feuer. 27 Prozent der gesamten Erlöse des Chipproduzenten kommen aus dem Reich der Mitte. Damit die nicht wegfallen, wandelt Intel auf den Suren... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 50,80 | -0,74 % | Zalando, RWE, Continental, MTU, Siemens Healthineers und BASF sind die Gewinner und Verlierer ... | Der DAX ISIN: DE0008469008 hat im Wochenverlauf 1,84 Prozent verloren und geht mit 17.930 Punkte ins Wochenende. Das Wochenhoch hat man am Montag gesehen und das Wochentief wurde am Freitagnachmittag... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 36,620 | +0,52 % | FMC-Aktie mit Kursverlusten (55,0585 €) | Im Minus liegt zur Stunde der Anteilsschein von FMC . Das Papier kostete zuletzt 58,59 US-Dollar. Eine Verbilligung in Höhe von 2,95 US-Dollar müssen derzeit die Aktionäre von FMC hinnehmen. Gegenwärtig... ► Artikel lesen | |
MOBILE-HEALTH NETWORK SOLUTIONS | 27,280 | +34,92 % | Mobile-health Network Solutions Makes History as First APAC Telehealth Company Listed on US Stock Exchange | SINGAPORE, April 15, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR), a pioneering Asia-Pacific (APAC) telehealth provider, celebrates its successful initial public offering... ► Artikel lesen | |
CARL ZEISS MEDITEC | 97,70 | +0,05 % | UBS stuft CARL ZEISS MEDITEC AG auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die schweizerische Großbank UBS hat die Einstufung für Carl Zeiss Meditec auf "Buy" mit einem Kursziel von 130 Euro belassen. Analyst Graham Doyle taucht in dieser am Freitag... ► Artikel lesen | |
GERRESHEIMER | 98,90 | -1,10 % | Gerresheimer: Gute Zahlen, schwache Aktie … was ist da los? | Der Verpackungsmittelspezialist Gerresheimer legte am Donnerstag die Ergebnisse für das erste Quartal vor, die vielleicht nicht hervorragend, aber doch leicht über den Prognosen ausfielen. Die Aktie... ► Artikel lesen | |
PROGYNY | 32,700 | +2,57 % | Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care | ||
AGILON HEALTH | 5,455 | +1,30 % | agilon health Reports Fourth Quarter 2023 Results | AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the fourth quarter... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 50,18 | -1,76 % | PROCEPT BioRobotics Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million | SAN JOSE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
ECKERT & ZIEGLER | 33,200 | -0,24 % | EQS-PVR: Eckert & Ziegler SE: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Eckert & Ziegler SE
Eckert & Ziegler SE: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
19.04.2024 / 20:57 CET/CEST
Veröffentlichung... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 18,100 | +1,57 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results | Achieved All 2023 Operating and Financial Guidance MetricsImplemented Providers +19.4% compared to Year-End 2022Introduces Full-Year 2024 GuidanceProactive Steps to Limit Downside Risk Arrangements... ► Artikel lesen | |
HIMS & HERS HEALTH | 11,195 | -3,45 % | Why Hims & Hers Stock Was Down This Week | ||
ADAPTHEALTH | 9,340 | -0,21 % | Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank | ||
NANO-X IMAGING | 8,600 | -5,18 % | Nano-X Imaging LTD.: Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold | - According to early findings in the ADOPT study, Nanox.AI software improves detection of key risk factor for osteoporosis, outperforming UK National Health Service national average - Findings... ► Artikel lesen | |
ATRICURE | 23,200 | -0,81 % | AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management |